CTM vs RARE · rev $52.9M vs rev $350.0M
Castellum Inc. (CTM) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Castellum Inc. (CTM) is a information technology services company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported CTM revenue for 2025-12-31 was $52.9M. Net income was -$2.4M. Revenue was up 18.1% from 2024-12-31 to 2025-12-31. CTM currently screens at market cap $67.0M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
CTM currently screens at market cap $67.0M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the CTM and RARE stock pages for the full models.
Not investment advice.